- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02586909
12-Month Open-Label Extension Study of Intepirdine (RVT-101) in Subjects With Alzheimer's Disease: MINDSET Extension
April 14, 2020 updated by: Axovant Sciences Ltd.
A Long-Term, Open-Label Extension Study of the Safety and Tolerability of RVT-101 in Subjects With Alzheimer's Disease
This 12-month open-label study will provide further information regarding the long-term safety and tolerability of intepirdine (RVT-101) for subjects with Alzheimer's disease who have completed the double-blind, placebo-controlled, lead-in study RVT-101-3001 (double-blind study).
Study Overview
Status
Terminated
Conditions
Intervention / Treatment
Detailed Description
This 12-month open-label study will provide further information regarding the long-term safety and tolerability of intepirdine (RVT-101) for subjects with Alzheimer's disease who have completed the double-blind, placebo-controlled, lead-in study RVT-101-3001.
Various background therapies, including acetylcholinesterase inhibitors and memantine, will be allowed.
Study Type
Interventional
Enrollment (Actual)
1099
Phase
- Phase 3
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Buenos Aires, Argentina, B1828CKR
- AR101
-
Buenos Aires, Argentina, C1199ABB
- AR060
-
Ciudad Autonoma de Buenos Aire, Argentina, C1012AAR
- AR084
-
Ciudad Autonoma de Buenos Aire, Argentina, C1058AAJ
- AR027
-
Ciudad Autonoma de Buenos Aire, Argentina, C1111AAL
- AR012
-
Ciudad Autonoma de Buenos Aire, Argentina, C1117ABH
- AR160
-
Ciudad Autonoma de Buenos Aire, Argentina, C1406BOA
- AR028
-
Ciudad Autonoma de Buenos Aire, Argentina, C1428AQK
- AR035
-
Ciudad Autónoma de Buenos Aire, Argentina, C1405BCK
- AR040
-
Ciudad Autónoma de Buenos Aire, Argentina, C1425AHQ
- AR081
-
Córdoba, Argentina, X5000DCE
- AR051
-
Córdoba, Argentina, X5000FJF
- AR137
-
Córdoba, Argentina, X5004AOA
- AR126
-
Mendoza, Argentina, M5501ACP
- AR210
-
Mendoza, Argentina, M5502AHV
- AR219
-
Santiago del Estero, Argentina, G4200DND
- AR059
-
-
Buenos Aires
-
La Plata, Buenos Aires, Argentina, A1902AJU
- AR130
-
-
-
-
-
Caulfield, Australia, VIC 3162
- AU227
-
Heidelberg West, Australia, VIC 3081
- AU032
-
Hornsby, Australia, NSW 2077
- AU011
-
West Perth, Australia, WA 6005
- AU138
-
-
-
-
-
Ruse, Bulgaria, 7003
- BU125
-
Sofia, Bulgaria, 1431
- BU131
-
Varna, Bulgaria, 9000
- BU073
-
-
-
-
British Columbia
-
Kelowna, British Columbia, Canada, V1Y 1Z9
- CA054
-
Kelowna, British Columbia, Canada, V1Y 4N7
- CA188
-
Penticton, British Columbia, Canada, V2A 5C8
- CA186
-
West Vancouver, British Columbia, Canada, V7T 2Z3
- CA141
-
-
Ontario
-
Newmarket, Ontario, Canada, L3Y 5G8
- CA147
-
North York, Ontario, Canada, M3B 2S7
- CA196
-
-
Quebec
-
Gatineau, Quebec, Canada, J8T 8JI
- CA236
-
-
-
-
II Región
-
Antofagasta, II Región, Chile, 1270244
- CH212
-
-
Region Metropolitana
-
Santiago, Region Metropolitana, Chile, 7560356
- CH076
-
-
Región Metropolitana
-
Santiago, Región Metropolitana, Chile, 7510186
- CH061
-
Santiago, Región Metropolitana, Chile, 7520338
- CH075
-
-
-
-
-
Zagreb, Croatia, 10000
- CR069
-
Zagreb, Croatia, 10000
- CR122
-
Zagreb, Croatia, 10090
- CR070
-
-
-
-
-
Praha, Czechia, 100 00
- CZE207
-
Praha 10, Czechia, 100 00
- CZE128
-
Praha 2, Czechia, 12000
- CZE132
-
Praha 6, Czechia, 160 00
- CZE129
-
Rychnov nad Kneznou, Czechia, 516 01
- CZE161
-
-
-
-
-
Lille Cedex, France, 59037
- FR231
-
Marseille Cedex 5, France, 13385
- FR182
-
Paris Cedex, France, 75013
- FR221
-
Villeurbanne, France, 69 100
- FR202
-
-
-
-
-
Bad Homburg, Germany, 61348
- GE206
-
Berlin, Germany, 10117
- GE091
-
Berlin, Germany, 12203
- GE071
-
Berlin, Germany, 13125
- GE139
-
Cologne, Germany, 50937
- GE230
-
Ellwangen, Germany, 73479
- GE252
-
Leipzig, Germany, 04107
- GE180
-
Mannheim, Germany, 68165
- GE228
-
Munchen, Germany, 81675
- GE017
-
Nürnberg, Germany, 90402
- GE157
-
Ulm, Germany, 89081
- GE098
-
Westerstede, Germany, 26655
- GE251
-
-
-
-
-
Brescia, Italy, 25125
- IT053
-
Cefalu, Italy, 90015
- IT124
-
Pavia, Italy, 27100
- IT030
-
Perugia, Italy, 06156
- IT103
-
Roma, Italy, 00168
- IT072
-
Roma, Italy, 00189
- IT029
-
Rome, Italy, 00179
- IT183
-
Rome, Italy, 00185
- IT175
-
Torino, Italy, 10 126
- IT085
-
-
-
-
-
Busan, Korea, Republic of, 49201
- SK066
-
Seoul, Korea, Republic of, 06351
- SK067
-
Seoul, Korea, Republic of, 07061
- SK190
-
-
-
-
-
Bialystok, Poland, 15-756
- PO013
-
Bydgoszcz, Poland, 85-080
- PO024
-
Bydgoszcz, Poland, 85-796
- PO010
-
Katowice, Poland, 40-123
- PO107
-
Katowice, Poland, 40-749
- PO092
-
Poznan, Poland, 61-853
- PO009
-
Szczecin, Poland, 70-111
- PO014
-
Warszawa, Poland, 01-697
- PO074
-
-
-
-
-
Belgrade, Serbia, 11 000
- SE164
-
Belgrade, Serbia, 11 000
- SE193
-
Belgrade, Serbia, 11000
- SE090
-
Kragujevac, Serbia, 34 000
- SE155
-
Novi Kneževac, Serbia, 23330
- SE031
-
Vršac, Serbia, 26300
- SE165
-
-
-
-
-
Singapore, Singapore, 119074
- SI052
-
Singapore, Singapore, 308433
- SI026
-
-
-
-
-
Banska Bystrica, Slovakia, 974 04
- SL056
-
Dubnica nad Vahom, Slovakia, 018 41
- SL200
-
Krompachy, Slovakia, 040 01
- SL078
-
Krompachy, Slovakia, 05342
- SL078
-
Svidník, Slovakia, 08901
- SL077
-
-
-
-
-
Alicante, Spain, 03690
- SP249
-
Barcelona, Spain, 08003
- SP176
-
Barcelona, Spain, 08028
- SP022
-
Barcelona, Spain, 08035
- SP021
-
Barcelona, Spain, 08036
- SP250
-
Barcelona, Spain, 08195
- SP184
-
Getxo, Spain, 48993
- SP222
-
San Sebastián, Spain, 20014
- SP194
-
-
-
-
-
Taoyuan, Taiwan, 333
- TA121
-
-
-
-
-
Bath, United Kingdom, BA1 3NG
- UK063
-
Blackpool, United Kingdom, FY2 0JH
- UK038
-
Cambridge, United Kingdom, CB21 5EF
- UK233
-
Carnoch, United Kingdom, WS11 0BN
- UK033
-
Epping, United Kingdom, CM16 6TN
- UK211
-
Guildford, United Kingdom, GU2 7YD
- UK234
-
Leeds, United Kingdom, LS10 1DU
- UK055
-
London, United Kingdom, W1G 9RU
- UK039
-
Manchester, United Kingdom, M13 9NQ
- UK034
-
Oxford, United Kingdom, OX3 9DU
- UK087
-
Plymouth, United Kingdom, PL5 8BT
- UK235
-
Sheffield, United Kingdom, S5 7JT
- UK100
-
Southampton, United Kingdom, SO16 6YD
- UK064
-
Southampton, United Kingdom, SO30 3JB
- UK152
-
Swindon, United Kingdom, SN3 6BW
- UK153
-
Warrington, United Kingdom, WA22 8WA
- UK154
-
-
-
-
Arizona
-
Phoenix, Arizona, United States, 85005
- US112
-
Tucson, Arizona, United States, 85704
- US220
-
-
California
-
Rancho Mirage, California, United States, 92270
- US096
-
Santa Ana, California, United States, 92705
- US195
-
Simi Valley, California, United States, 93065
- US016
-
Temecula, California, United States, 92591
- US106
-
-
Connecticut
-
Hamden, Connecticut, United States, 06518
- US179
-
Norwich, Connecticut, United States, 06360
- US171
-
-
Florida
-
Atlantis, Florida, United States, 33462
- US088
-
Brooksville, Florida, United States, 34601
- US007
-
Hallandale Beach, Florida, United States, 33009
- US002
-
Hialeah, Florida, United States, 33012
- US140
-
Miami, Florida, United States, 33137
- US216
-
Miami, Florida, United States, 33165
- US110
-
North Palm Beach, Florida, United States, 33408
- US172
-
Orlando, Florida, United States, 32806
- US003
-
Pensacola, Florida, United States, 32502
- US256
-
Tampa, Florida, United States, 33613
- US037
-
Tampa, Florida, United States, 33613
- US042
-
The Villages, Florida, United States, 32162
- US004
-
-
Georgia
-
Atlanta, Georgia, United States, 30331
- US048
-
Atlanta, Georgia, United States, 30342
- US046
-
Columbus, Georgia, United States, 31909
- US217
-
-
Louisiana
-
Baton Rouge, Louisiana, United States, 70808
- US111
-
Shreveport, Louisiana, United States, 71104
- US095
-
-
Massachusetts
-
Newton, Massachusetts, United States, 02459
- US116
-
Quincy, Massachusetts, United States, 02169
- US174
-
-
Mississippi
-
Hattiesburg, Mississippi, United States, 39401
- US144
-
-
Nevada
-
Las Vegas, Nevada, United States, 89113
- US094
-
-
New Jersey
-
Berlin, New Jersey, United States, 08009
- US135
-
Lawrenceville, New Jersey, United States, 08648
- US197
-
Manchester, New Jersey, United States, 08759
- US057
-
Mount Arlington, New Jersey, United States, 07856
- US215
-
Toms River, New Jersey, United States, 08755
- US209
-
West Long Branch, New Jersey, United States, 07764
- US036
-
-
New York
-
Albany, New York, United States, 12208
- US001
-
Brooklyn, New York, United States, 11235
- US049
-
New Hyde Park, New York, United States, 11040
- US097
-
New York, New York, United States, 10022
- US044
-
-
North Carolina
-
Chapel Hill, North Carolina, United States, 27599
- US150
-
Charlotte, North Carolina, United States, 28270
- US185
-
-
Ohio
-
Cincinnati, Ohio, United States, 45227
- US008
-
Cleveland, Ohio, United States, 44106
- US113
-
Shaker Heights, Ohio, United States, 44122
- US119
-
-
Oregon
-
Portland, Oregon, United States, 97210
- US134
-
-
Pennsylvania
-
Media, Pennsylvania, United States, 19063
- US169
-
Plains, Pennsylvania, United States, 18075
- US162
-
Willow Grove, Pennsylvania, United States, 19001
- US148
-
-
Texas
-
San Antonio, Texas, United States, 78229
- US043
-
-
Utah
-
Orem, Utah, United States, 84058
- US143
-
-
Virginia
-
Charlottesville, Virginia, United States, 22903
- US149
-
-
Washington
-
Spokane, Washington, United States, 99202
- US170
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
50 years to 86 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Completed last on-treatment visit of the lead-in study RVT-101-3001
Exclusion Criteria:
- Any clinically relevant concomitant disease, which, in the opinion of the investigator, makes the subject unsuitable for inclusion in the study.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: RVT-101 35 mg tablets
once daily, oral tablets
|
once daily, oral tablets
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Occurrence of Adverse Events (AEs) and or Reported Changes in Physical Examinations, Vital Signs Measurements, Electrocardiograms (ECGs), Routine Laboratory Assessments
Time Frame: Baseline to 12 months or Early Termination
|
The primary outcome measure is to study the safety of Intepridine (RVT-101) by determining the incidence of AEs, changes in physical examinations, vital signs measurements, ECGs and clinical laboratory assessments
|
Baseline to 12 months or Early Termination
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Study Director: Ilise Lombardo, MD, Axovant Sciences, Inc., Vice President, Clinical Research
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
April 26, 2016
Primary Completion (Actual)
March 12, 2018
Study Completion (Actual)
March 12, 2018
Study Registration Dates
First Submitted
October 23, 2015
First Submitted That Met QC Criteria
October 23, 2015
First Posted (Estimate)
October 27, 2015
Study Record Updates
Last Update Posted (Actual)
April 17, 2020
Last Update Submitted That Met QC Criteria
April 14, 2020
Last Verified
March 1, 2018
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- RVT-101-3002
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Alzheimer's Disease
-
University of Southern CaliforniaAlzheimer's Therapeutic Research Institute; American Heart Association; Schaeffer...RecruitingDementia | Alzheimer Disease | Prodromal Alzheimer's Disease | Preclinical Alzheimer's DiseaseUnited States
-
University of Southern CaliforniaNational Institute on Aging (NIA); Alzheimer's Therapeutic Research Institute; Brigham and Women's Hospital and other collaboratorsRecruitingDementia | Alzheimer Disease | Prodromal Alzheimer's Disease | Preclinical Alzheimer's DiseaseUnited States
-
Novoic LimitedRecruitingAlzheimer Disease | Mild Cognitive Impairment | Prodromal Alzheimer's Disease | Alzheimer's Disease (Incl Subtypes) | Preclinical Alzheimer's DiseaseUnited States
-
Novoic LimitedRecruitingAlzheimer Disease | Mild Cognitive Impairment | Prodromal Alzheimer's Disease | Alzheimer's Disease (Incl Subtypes) | Preclinical Alzheimer's DiseaseUnited Kingdom
-
Novoic LimitedCompletedAlzheimer Disease | Mild Cognitive Impairment | Prodromal Alzheimer's Disease | Alzheimer's Disease (Incl Subtypes) | Preclinical Alzheimer's DiseaseUnited States
-
Novoic LimitedCompletedAlzheimer Disease | Mild Cognitive Impairment | Prodromal Alzheimer's Disease | Alzheimer's Disease (Incl Subtypes) | Preclinical Alzheimer's DiseaseUnited Kingdom
-
Novoic LimitedRecruitingAlzheimer Disease | Mild Cognitive Impairment | Prodromal Alzheimer's Disease | Alzheimer's Disease (Incl Subtypes) | Preclinical Alzheimer's DiseaseUnited Kingdom
-
Novoic LimitedRecruitingAlzheimer Disease | Mild Cognitive Impairment | Prodromal Alzheimer's Disease | Alzheimer's Disease (Incl Subtypes) | Preclinical Alzheimer's Disease | Normal CognitionUnited States
-
University Hospital, BordeauxMinistry for Health and Solidarity, FranceCompletedAlzheimer's Disease (AD) | Alzheimer's Disease (AD) Related DisordersFrance
-
University of Colorado, DenverNational Institute on Aging (NIA)Active, not recruitingSuspected Typical Alzheimer's Disease (AD) | Suspected Atypical Alzheimer's Disease (AD)United States
Clinical Trials on RVT-101 35 mg tablets
-
Axovant Sciences Ltd.TerminatedDementia With Lewy BodiesUnited States, Canada, France, Italy, Netherlands, Spain, United Kingdom
-
Axovant Sciences Ltd.CompletedDementia With Lewy BodiesUnited States, Canada, France, Italy, Netherlands, Spain, United Kingdom
-
Axovant Sciences Ltd.CompletedAlzheimer's Disease | Dementia With Lewy Bodies | Parkinson's Disease DementiaUnited States
-
Immunovant Sciences GmbHTerminatedWarm Autoimmune Hemolytic AnemiaUnited States, Korea, Republic of, Israel, United Kingdom, Spain, Thailand
-
Axovant Sciences Ltd.CompletedAlzheimer's DiseaseUnited States, Argentina, Australia, Bulgaria, Canada, Chile, Croatia, France, Germany, Italy, Korea, Republic of, Poland, Serbia, Singapore, Slovakia, Spain, Taiwan, United Kingdom, Czechia
-
Zhejiang Hisun Pharmaceutical Co. Ltd.Unknown
-
Transposon Therapeutics, Inc.Active, not recruitingProgressive Supranuclear PalsyUnited States
-
Emerald Health PharmaceuticalsSuspendedRelapsing Forms of Multiple SclerosisUnited States, Australia
-
Cara Therapeutics, Inc.RecruitingPruritus | Notalgia ParestheticaUnited States, Poland, Spain, Canada, Germany
-
GlaxoSmithKlineTerminatedPulmonary Disease, Chronic ObstructiveUnited States